Technology / Scientific & Technical InstrumentsNYSE American
$0.33
-0.01 (-2.94%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-10.4M · quality 66.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
14/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$129M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-22.8%
↓Gross Margin
N/A
•Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
—
FCF / Net income
0.34x
Latest source
Provider fallback
Margin decomposition
Último año: revenue — · net income $-22.1M · FCF $-7.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | — | — | — | — | $4.4M | $0.00 | $121939.00 | $1.8M | $4.3M | $4.9M | — | — | — | — | — | — | — | — |
| Net Income | $-22.1M | $-22.1M | $-16.6M | $-15.3M | $-20.1M | $-25.4M | $-13.6M | $-7.6M | $-3.3M | $-3.9M | $-1.7M | $-2.6M | $-1.0M | $-6.6M | $-2.7M | $-2.4M | $-1.1M | $-950609.00 |
| EBITDA | $-19.3M | $-19.3M | $-14.8M | $-14.4M | $-11.7M | $-10.2M | $-6.6M | $-4.8M | $-2.1M | $-3.2M | $-2.5M | $-2.0M | $-2.1M | $-3.5M | $-1.9M | $-1.9M | $-931645.00 | $-897048.00 |
| EPS | -0.39 | -0.39 | -7.85 | -16.40 | -20.00 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | 21.3% | — | 42.8% | 23.6% | 19.1% | 18.6% | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | -288.4% | — | -5597.8% | -277.7% | -52.5% | -66.5% | — | — | — | — | — | — | — | — |
| Net Margin | — | — | — | — | -460.3% | — | -11122.5% | -421.7% | -75.7% | -80.0% | — | — | — | — | — | — | — | — |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 0.00 | 0.00 | -2.36 | 0.78 | 0.26 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.02 | -0.63 | -0.88 | — |
| Current Ratio | 0.32 | 0.32 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $-7.6M | $-7.6M | $-12.9M | $-10.4M | $-7.8M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Returns | ||||||||||||||||||
| ROE | -22.8% | -22.8% | 769.0% | -408.4% | -203.5% | -2041.6% | 708.3% | 230.9% | 124.9% | 98.5% | 62.2% | 48.9% | 29.8% | 235.9% | -1601.2% | 149.6% | 60.5% | 69.6% |
| Valuation | ||||||||||||||||||
| P/B | 0.22 | 0.22 | — | 3.31 | 7.74 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | — | — | — | — | — | -100.0% | -93.2% | -58.1% | -11.7% | — | — | — | — | — | — | — | — | — |
| EPS Growth | 95.0% | 95.0% | 52.1% | 18.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-34.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-7.85 → -0.39
Residual
-34.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.